よむ、つかう、まなぶ。
【参考資料２－１】抗微生物薬適正使用の手引き 第四版（案）医科・外来編 (49 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64503.html |
| 出典情報 | 厚生科学審議会 感染症部会（第99回 10／21）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
抗微生物薬適正使用の手引き
第四版
医科・外来編
40. Shah M, Centor RM, Jennings M. Severe acute pharyngitis caused by group C
streptococcus. J Gen Intern Med. 2007. 22:272-4.
41. Centor RM. Expand the pharyngitis paradigm for adolescents and young adults. Ann Intern
Med. 2009. 151:812-5.
42. Jensen A, et al. Fusobacterium necrophorum tonsillitis: an important cause of tonsillitis in
adolescents and young adults. Clin Microbiol Infect. 2015. 21:266.e1-3.
43. Hedin K, et al. The aetiology of pharyngotonsillitis in adolescents and adults - Fusobacterium
necrophorum is commonly found. Clin Microbiol Infect. 2015. 21:263.e1-7.
44. Centor RM, et al. The Clinical Presentation of Fusobacterium-Positive and StreptococcalPositive Pharyngitis in a University Health Clinic: A Cross-sectional Study. Ann Intern Med.
2015. 162:241-7.
45. McIsaac WJ, et al. The validity of a sore throat score in family practice. CMAJ. 2000.
163:811-5.
46. McIsaac WJ, et al. Empirical validation of guidelines for the management of pharyngitis in
children and adults. JAMA. 2004. 291:1587-95.
47. Group ESTG, Pelucchi C, Grigoryan L, et al. Guideline for the management of acute sore
throat. Clin Microbiol Infect. 2012. 18 Suppl 1:1-28.
48. 感染症治療ガイド・ガイドライン作成委員会編 JJ. Ⅵ 急性扁桃炎・咽頭炎. JAID/JSC 感染
症治療ガイドライン 2023. 東京: 杏林舎; 2023. p. 92-103.
49. McGinn TG, et al. Validation and modification of streptococcal pharyngitis clinical prediction
rules. Mayo Clin Proc. 2003. 78:289-93.
50. Humair J-P, et al. Management of acute pharyngitis in adults: reliability of rapid streptococcal
tests and clinical findings. Arch Intern Med. 2006. 166:640-4.
51. Fine AM, et al. Large-scale validation of the Centor and McIsaac scores to predict group A
streptococcal pharyngitis. Arch Intern Med. 2012. 172:847-52.
52. Llor C, et al. Validity of a point-of-care based on heterophile antibody detection for the
diagnosis of infectious mononucleosis in primary care. Eur J Gen Pract. 2012. 18:15-21.
53. Ebell MH, et al. Does This Patient Have Infectious Mononucleosis? JAMA. 2016. 315:15028.
54. Wolf DM, et al. Lymphocyte-white blood cell count ratio: a quickly available screening tool to
differentiate acute purulent tonsillitis from glandular fever. Arch Otolaryngol Head Neck Surg.
2007. 133:61-4.
55. 岸田直樹. 誰も教えてくれなかった「風邪」の診かた: 感染症診療 12 の戦略 第二版. 東京:
医学書院; 2019.
56. 山本舜悟. かぜ診療マニュアル―かぜとかぜにみえる重症疾患の見わけ方 第 3 版. 東京: 日本
医事新報社; 2019. 2019-10-13.
57. Ebell MH, et al. How Long Does a Cough Last? Comparing Patients' Expectations With Data
From a Systematic Review of the Literature. Ann Fam Med. 2013. 11:5-13.
58. 感染症治療ガイド・ガイドライン作成委員会編 JJ. V 中耳炎および鼻副鼻腔炎. JAID/JSC
感染症治療ガイドライン 2023. 東京: 杏林舎; 2023. p. 70−91.
59. Cornia PB. Does This Coughing Adolescent or Adult Patient Have Pertussis? JAMA. 2010.
304:890-6.
60. de Melker HE, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies
against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella
pertussis. J Clin Microbiol. 2000. 38:800-6.
49
第四版
医科・外来編
40. Shah M, Centor RM, Jennings M. Severe acute pharyngitis caused by group C
streptococcus. J Gen Intern Med. 2007. 22:272-4.
41. Centor RM. Expand the pharyngitis paradigm for adolescents and young adults. Ann Intern
Med. 2009. 151:812-5.
42. Jensen A, et al. Fusobacterium necrophorum tonsillitis: an important cause of tonsillitis in
adolescents and young adults. Clin Microbiol Infect. 2015. 21:266.e1-3.
43. Hedin K, et al. The aetiology of pharyngotonsillitis in adolescents and adults - Fusobacterium
necrophorum is commonly found. Clin Microbiol Infect. 2015. 21:263.e1-7.
44. Centor RM, et al. The Clinical Presentation of Fusobacterium-Positive and StreptococcalPositive Pharyngitis in a University Health Clinic: A Cross-sectional Study. Ann Intern Med.
2015. 162:241-7.
45. McIsaac WJ, et al. The validity of a sore throat score in family practice. CMAJ. 2000.
163:811-5.
46. McIsaac WJ, et al. Empirical validation of guidelines for the management of pharyngitis in
children and adults. JAMA. 2004. 291:1587-95.
47. Group ESTG, Pelucchi C, Grigoryan L, et al. Guideline for the management of acute sore
throat. Clin Microbiol Infect. 2012. 18 Suppl 1:1-28.
48. 感染症治療ガイド・ガイドライン作成委員会編 JJ. Ⅵ 急性扁桃炎・咽頭炎. JAID/JSC 感染
症治療ガイドライン 2023. 東京: 杏林舎; 2023. p. 92-103.
49. McGinn TG, et al. Validation and modification of streptococcal pharyngitis clinical prediction
rules. Mayo Clin Proc. 2003. 78:289-93.
50. Humair J-P, et al. Management of acute pharyngitis in adults: reliability of rapid streptococcal
tests and clinical findings. Arch Intern Med. 2006. 166:640-4.
51. Fine AM, et al. Large-scale validation of the Centor and McIsaac scores to predict group A
streptococcal pharyngitis. Arch Intern Med. 2012. 172:847-52.
52. Llor C, et al. Validity of a point-of-care based on heterophile antibody detection for the
diagnosis of infectious mononucleosis in primary care. Eur J Gen Pract. 2012. 18:15-21.
53. Ebell MH, et al. Does This Patient Have Infectious Mononucleosis? JAMA. 2016. 315:15028.
54. Wolf DM, et al. Lymphocyte-white blood cell count ratio: a quickly available screening tool to
differentiate acute purulent tonsillitis from glandular fever. Arch Otolaryngol Head Neck Surg.
2007. 133:61-4.
55. 岸田直樹. 誰も教えてくれなかった「風邪」の診かた: 感染症診療 12 の戦略 第二版. 東京:
医学書院; 2019.
56. 山本舜悟. かぜ診療マニュアル―かぜとかぜにみえる重症疾患の見わけ方 第 3 版. 東京: 日本
医事新報社; 2019. 2019-10-13.
57. Ebell MH, et al. How Long Does a Cough Last? Comparing Patients' Expectations With Data
From a Systematic Review of the Literature. Ann Fam Med. 2013. 11:5-13.
58. 感染症治療ガイド・ガイドライン作成委員会編 JJ. V 中耳炎および鼻副鼻腔炎. JAID/JSC
感染症治療ガイドライン 2023. 東京: 杏林舎; 2023. p. 70−91.
59. Cornia PB. Does This Coughing Adolescent or Adult Patient Have Pertussis? JAMA. 2010.
304:890-6.
60. de Melker HE, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies
against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella
pertussis. J Clin Microbiol. 2000. 38:800-6.
49